Skip to Content

MYLAN 2046 MYLAN 2046 (Tacrolimus 1 mg)

Pill imprint MYLAN 2046 MYLAN 2046 has been identified as Tacrolimus 1 mg.

Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tacrolimus 1 mg MYLAN 2046 MYLAN 2046
Tacrolimus 1 mg MYLAN 2046 MYLAN 2046
Discount Card Promo
Tacrolimus
Imprint:
MYLAN 2046 MYLAN 2046
Strength:
1 mg
Color:
Blue & Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2046
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
gelatin
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
FD&C Blue No. 1
FD&C Red No. 3
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0818 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide